Mary Ann Liebert: Tracking Adeno-Associated Virus Capsid Evolution
March 19, 2020
March 19, 2020
NEW ROCHELLE, New York, March 19 -- Mary Ann Liebert Inc. issued the following news release:
Researchers have used high-throughput screening of adeno-associated viral (AAV) vector capsid libraries to maximize the likelihood of obtaining AAV variants with desired properties. As a result of these experiments, they gained some unexpected insights, reported in an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Mark . . .
Researchers have used high-throughput screening of adeno-associated viral (AAV) vector capsid libraries to maximize the likelihood of obtaining AAV variants with desired properties. As a result of these experiments, they gained some unexpected insights, reported in an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Mark . . .